MEDIX RESOURCES INC
NT 10-Q, 1998-08-12
HELP SUPPLY SERVICES
Previous: REVLON CONSUMER PRODUCTS CORP, 10-Q, 1998-08-12
Next: TACO CABANA INC, 10-Q, 1998-08-12



                                 FORM 12B-25
                                SEC FILE NUMBER
                                    0-19333

                    U.S. SECURITIES AND EXCHANGE COMMISSION

                            WASHINGTON, D.C. 20459

                                  FORM 12B-25

                          NOTIFICATION OF LATE FILING

                                 (Check One):
[  ]  Form 10-K and 10-KSB  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-QSB  [ ]
Form  N-SAR
     For  Period  Ended:          June  28,  1998
     [  ]  Transition  Report  on  Form  10-K
     [  ]  Transition  Report  on  Form  20-F
     [  ]  Transition  Report  on  Form  11-K
     [  ]  Transition  Report  on  Form  10-Q
     [  ]  Transition  Report  on  Form  N-SAR
     For  the  Transition  Period  Ended:


     Read  Attached  Instruction Sheet Before Preparing Form.  Please Print or
Type.
     Nothing  in this form shall be construed to imply that the Commission has
verified  any  information  contained  herein.


     If  the  notification  related  to a portion of the filing checked above,
identify  the  Item(s)  to  which  the  notification  relates:



PART  I-REGISTRANT  INFORMATION


     MEDIX  RESOURCES,  INC.
     (Full  name  of  Registrant)

     7100  E  BELLEVIEW  AVENUE,  SUITE  301
     (Address  of  Principal  Executive  Office)

     ENGLEWOOD,  COLORADO      80111
     (City  State  Zip)

PART  II.RULES  12B.25(B)  AND  (C)

If  the  subject  report  could  not  be  filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule 12b.25(b), the
following  should  be  completed.  (Check  box  if  appropriate)

     (a)  The  reasons described in reasonable detail in Part III of this form
could  not  be  eliminated  without  unreasonable  effort  or  expense;

X      (b) The subject annual report, semi-annual report, transition report on
Form 10.K, Form 10-KSB, Form 20-F, 11.K or Form N.SAR, or portion thereof will
be  filed on or before the fifteenth calendar day following the prescribed due
date;  or  the  subject  quarterly report or transition report on Form 10.Q or
Form  10-QSB, or portion thereof will be filed on or before the fifth calendar
day  following  the  prescribed  due  date;  and

     (c)  The  accountant's  statement  or  other  exhibit  required  by  Rule
12b.25(c)  has  been  attached  if  applicable.

<PAGE>
- ------

PART  III.  NARRATIVE


State  below  in reasonable detail the reasons why Form 10-K and 10-KSB, 20-F,
11-K, 10-Q and 10-QSB, N-SAR or the transition report or portion thereof could
not  be  filed  within  the  prescribed  time  period.

     MORE  TIME  IS  NEEDED  TO  ACCUMULATE  INFORMATION.


PART  IV.  OTHER  INFORMATION

     (1)  Name  and  telephone  number  of person to contact in regard to this
notification

   John  P.  Yeros      (303)                  741-4828
     (Name)          (Area  Code)          (Telephone  Number)
     (2) Have all other periodic reports required under section 13 or 15(d) of
the  Securities  Exchange  Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant  was  required to file such report(s) been filed?  If the answer is
no,  identify  report(s).
          [X]  Yes          [  ]  No
     (3)  Is  it  anticipated  that  any  significant  change  in  results  of
operations  from  the  corresponding  period  for the last fiscal year will be
reflected  by  the earnings statements to be included in the subject report or
portion  thereof?
          [  ]  Yes          [X]  No

     If  so, attach an explanation of the anticipated change, both narratively
and  quantitatively,  and,  if appropriate, state the reasons why a reasonable
estimate  of  the  results  cannot  be  made.


                             MEDIX RESOURCES, INC.

has  caused  this  notification  to be signed on its behalf by the undersigned
thereunto  duly  authorized.

Date       August 12, 1998     /s/ John P. Yeros, Chairman and Chief Executive
Officer
INSTRUCTION:  The form may be signed by an executive officer of the registrant
or  by  any  other  duly authorized representative.  The name and title of the
person  signing  the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the  registrant  by  an authorized
representative  (other  than  an  executive  officer),  evidence  of  the
representative's  authority to sign on behalf of the registrant shall be filed
with  the  form.


                                   ATTENTION
     Intentional  misstatements  or  omissions  of  fact  constitute  Federal
Criminal  Violations  (See  18  U.S.C.  1001).








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission